Leaders in regenerative medicine, advanced therapies, diagnostics and technologies come together to share breakthroughs and accelerate progress in healthcare

Sidra Medicine, a member of the Qatar Foundation for Education, Science and Community Development and Qatar’s new hospital for children, young people, and women, has once again demonstrated its leadership in delivering the National Health Strategy 2030 by hosting one of Qatar’s highest profile events dedicated to accelerating advanced and experimental therapies.

This widely anticipated two-day conference which starts on Saturday 28th October brings together world-leading experts and practitioners from 10 countries to share knowledge and research and spur innovation in advanced treatments ranging from cellular, gene therapy, molecular targeted therapies and immunotherapy.

The one-of-a-kind event is the latest in the Sidra Symposia Series, a popular program that has attracted a large following in the country by equipping attendees to practice at the leading-edge of their field through accessing knowledge, ideas and best practice in a wide variety of clinical areas.

The upcoming conference will feature leading figures and experts from the Middle East, Europe and US. Key international speakers at the event include Soldano Ferrone, Faculty member of the Department of Surgery at Massachusetts General Hospital, Harvard Medical School, Adrian Thrasher, Professor of Paediatric Immunology at UCL Great Ormond Street Institute of Child Health, and Michele Maio, Director of the Center for Immuno-Oncology at University Hospital of Siena, amongst many others.

Providing a rich mixture of workshop sessions and keynote lectures, the conference is open to physicians, nurses, pharmacists, allied health providers, medical students and other practitioners who care for patients with oncological, hematological, immunology, inflammatory and autoimmune disorders. Attendance at the symposium provides a major boost to participant’s Continuing Medical Education (CME), since it is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department. Attendees can earn 14.75 CME points.The conference takes place at the Four Seasons Hotel from 07:00 to 17:00 on 28th and 29th October. Spaces are filling up fast with limited time for interested parties to secure their attendance. Tickets are available at http://events.sidra.org/event/advanced-therapies-in-healthcare/ A limited number of spaces are available for on-site registration on both days. 

Dr Chiara Cugno, Director of Clinic Research at Sidra Medicine said: “At Sidra, we’re committed to creating effective platforms for healthcare professionals to collaborate, share best practices and methodologies and to developing programs that advance personalized medicine in Qatar and beyond. We look forward to welcoming large numbers of the country’s leading medical practitioners to come together and play their part in accelerating advanced therapy development. This conference is a critical part of our long-term goal to boost the introduction of advanced treatments, especially in cell and gene therapy in Qatar. It goes a long way towards supporting our ambition to introduce ground-breaking technologies and techniques that will significantly improve the lives of children, young people and women in the country.”

The conference will help ongoing research and drive scientific knowledge in the area of translational research and early clinical applications. Specifically, it will shed light into the development phases, clinical trials, and regulatory aspects of these therapies, particularly in the field of Oncology, Hematology, Immunology, Inflammatory and Autoimmune disorders, to engender better and more personalized treatment options, and ultimately bring important health benefits.

Sidra Medicine forms an integral part of the dynamic community development environment of Qatar Foundation, providing world-class patient care locally and helping to position Qatar as a leading center of excellence for healthcare globally. As a member of Qatar Foundation, and through strong partnerships with leading institutions in Qatar and around the world, Sidra Medicine helps to advance scientific discovery through investment in medical research.

To register for the Advanced Therapies symposium, please visit: http://events.sidra.org/event/advanced-therapies-in-healthcare/

-Ends-

  • Sidra Medicine’s mission is to be a beacon of learning, discovery and exceptional care, ranked among the top academic medical centers in the world.
  • Sidra Medicine, a member of Qatar Foundation for Education, Science and Community Development, represents the vision of Her Highness Sheikha Moza bint Nasser who serves as its Chairperson.
  • Sidra Medicine’s values are trust, care, teamwork, transparency, innovation and efficiency
  • Sidra Medicine will provide world-class healthcare services for children, young people and women in Qatar and internationally
  • Sidra Medicine’s research program will help develop ground-breaking treatments, technologies and techniques, especially in the areas of Maternal Fetal Medicine, Genetics and Genomics and Maternal Diabetes and Metabolic Syndromes

Once fully operational, Sidra Medicine:

  • Will become the leading pediatric hospital in Qatar.
  • Will be the only specialist center treating pregnant women with fetal complications.
  • Will handle 275,000 outpatient appointments, 11,000 procedures, 100,000 emergency attendances and deliver over 9,000 babies.
  • Will feature 140 clinic rooms, 10 operating theatres, 400 beds, 100 per cent single rooms with a private bathroom, a birthing center and emergency department.
  • Will employ 2,000 nurses, 600 doctors and 800 other health care professionals, as well as administrative staff.

Sidra Medicine outpatient services launched on 1 May 2016 and now operates 47 clinics and services related to pediatric and obstetrics care for the children, young people and women of Qatar.

Sidra Medicine is located in Education City, Doha.

For further information, please visit http://www.sidra.org/

© Press Release 2017